Chromanes inhibit basal proton conductance of UCP1 and UCP2 and sensitise HT-29 colon cancer cells to commonly used chemotherapeutic agents such as cisplatin and doxorubicin (Rial et al, 2011). The gene discussed is UCP2; the disease is colonic neoplasm.